⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2)

Official Title: Long-term Effects of Aldara® 5% Cream and Solaraze® 3% Gel in the Treatment of Actinic Keratoses on the Face or Scalp With Respect to the Risk of Progression to In-situ and Invasive Squamous Cell Carcinoma

Study ID: NCT01453179

Interventions

Imiquimod
Diclofenac

Study Description

Brief Summary: This clinical trial serves the purpose to compare the long-term effects of a treatment of actinic keratosis - your skin disorder - using Aldara® 5% cream (Imiquimod) or Solaraze® 3% gel (Diclofenac) on the face or the scalp. In particular, it should be found out whether the healing effect of these two medications on the skin lesions (i.e. the damaged skin parts) can be maintained for a prolonged period.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Medical University Graz, University Clinic for Dermatology and Venerology Graz, Graz, , Austria

Medical Practice, Maria Enzersdorf, , Austria

Medical University Vienna, Department for General Dermatology, Vienna, , Austria

Medical Supply Center, Augsburg, , Germany

Licca Clinical Research Institute, Clinic for Dermatolgy and Surgery, Augsburg, , Germany

Medical Practice, Berlin, , Germany

Medical Practice, Duelmen, , Germany

Medical Practice, Germering, , Germany

Medical Department of Otto-von-Guericke-University Magdeburg, University Clinic for Dermatology and Venerology, Magdeburg, , Germany

Medical Practice, Mahlow, , Germany

Department of Dermatology Johannes Gutenberg-University Mainz, Clinical Research Center, Mainz, , Germany

Medical Practice, Markkleeberg, , Germany

Medical Practice for Dermatology and Medical Cosmetics, Mönchengladbach, , Germany

Medical Practice, Münster, , Germany

Derma Center Vechta, Clinic for Dermatology, Vechta, , Germany

Centrovital, Medical Practice for Dermatology, Witten, , Germany

Medical Practice for Dermatology and Venerology, Wuppertal, , Germany

Contact Details

Name: Ursula Petzold, Dr.

Affiliation: MEDA Pharma GmbH & Co. KG

Role: STUDY_DIRECTOR

Name: Harald Gollnick, Prof. Dr.

Affiliation: Otto-von-Guericke-University of Magdeburg

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: